Tirzepatide targets two hormones for appetite regulation, making it potentially more effective for certain patients seeking weight loss
The goal is to understand patterns: what happens after dose day, what foods feel better or worse, whether you are eating enough protein, whether water or fiber affects constipation, and what you should bring up with your clinician
A key difference between these peptides is that while they both appear to increase the secretion and production of HGH in vitro and in vivo, only tesamorelin has undergone human clinical trials and has been approved by the FDA
Therefore, semaglutide and tirzepatide do not treat: rheumatoid arthritis psoriatic arthritis lupus Sjgrens syndrome multiple sclerosis inflammatory bowel disease They may improve metabolic inflammation in patients who also have autoimmune diseasebut they do not treat the autoimmune condition itself
#CrystalTomato #SkinConfidenceFromScience | Crystal Tomato Singapore